Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951)

Author： Haberkorn Brigitte CM Eskens Ferry ALM

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.1, 2013-01, pp. : 13-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-clinical development of farnesyltransferase inhibitors

By Lobell R.B. Kohl N.E.

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 203-210

Springer Publishing Company

Access to resources Recommend Favorite

Roles of Casein Kinase I η and &dgr; in Gastrointestinal Cancers: Potential New Screening Markers and Drug Targets

Current Cancer Therapy Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 151-157

Bentham Science Publishers

Access to resources Recommend Favorite

Adenovirus/PSA (Ad5-PSA) Vaccination for Prostate Cancer: Pre-Clinical and Clinical Development

Current Cancer Therapy Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 271-273

Bentham Science Publishers

Access to resources Recommend Favorite

Vitespen: a preclinical and clinical review

By Wood Christopher G Mulders Peter

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 763-774

Future Medicine

Access to resources Recommend Favorite

Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping

By Tanaka Eiichi Choi Hak Fujii Hirofumi Bawendi Moungi Frangioni John

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1671-1681

Springer Publishing Company

Access to resources Recommend Favorite